Treatment of Klebsiella pneumoniae

summary

There are many kinds of pneumonia diseases. In the treatment of pneumonia diseases, we should first understand the pneumonia diseases. The symptoms, etiology and clinical manifestations of different pneumonia are different. Therefore, the choice of treatment methods is also very different. Many people are not familiar with Klebsiella pneumoniae pneumonia. What are the problems with the symptoms of Klebsiella pneumoniae pneumonia? Here are the details Under the introduction of, make all have some understanding.

Treatment of Klebsiella pneumoniae

First, Klebsiella infection. Klebsiella is a kind of Gram-negative bacteria with capsule in Enterobacteriaceae. Klebsiella pneumoniae, Klebsiella odorifera and Klebsiella rhinoscleroderma are closely related to human beings. Among them, Klebsiella pneumoniae is the most important, and its diseases account for more than 95% of Klebsiella infections.

Second, some people think that the above three species are biochemical types of Klebsiella aerogenes. Klebsiella pneumoniae is an important pathogen of respiratory tract infection. It often causes severe pneumonia, urinary tract infection, biliary tract infection, sepsis and purulent meningitis. Infection often occurs in hospitalized patients with weakness. Pathogens often inhale from the upper respiratory tract, or invade the human body through contaminated respirators, nebulizers or various catheters. The hands of medical staff also play an important role in cross infection.

Third: pneumonia has become one of the important pathogenic bacteria of nosocomial infection, accounting for the first place of nosocomial infection in some countries. The combination of cephalosporin and gentamicin can control Klebsiella infection. Because bacteria are often resistant to many kinds of antibiotics, the prognosis of the disease is poor and the mortality is high (50% in severe cases).

matters needing attention

Pneumonobacterial pneumonia accounts for 1-2% of bacterial pneumonia. Its pathological changes are similar to those of Streptococcus pneumoniae pneumonia, which leads to consolidation of lung lobes or segments (alveoli filled with inflammatory exudates). The difference is that the growth and reproduction of pneumonia bacteria is fast, destructive, the exudate is thick and heavy, containing a large number of drugs for the treatment of Klebsiella infection, the encapsulated pneumonia bacteria; it often causes necrosis and liquefaction of alveolar wall and lung tissue, and pleural involvement, so the incidence of lung abscess and empyema is higher than that of Streptococcus pneumoniae pneumonia.